Skip to main content
. 2020 Jun 30;1(8):731–739. doi: 10.34067/KID.0002252020

Figure 1.

Figure 1.

Stratification by KidneyIntelX predicted risk classified more patients correctly for the composite kidney end point than stratification with predicted risk derived from the clinical model in both T2D and APOL1-HR population. (A) T2D cohort and (B) APOL1 –HR cohort. In those with T2D, a higher proportion of patients in the top 2 deciles of KidneyIntelX predicted risk experienced the composite kidney end point than those in the top 2 deciles of the clinical model and a lower proportion of patients with T2D classified in the bottom 3 deciles of risk experienced the composite kidney end point than those in the bottom 3 deciles of the clinical model. In those with APOL1-HR genotypes, a higher proportion in the top 3 deciles of KidneyIntelX predicted risk experienced the composite kidney end point than those in the top 3 deciles of the clinical model and a lower proportion of those in the lower 7 deciles of KidneyIntelX experienced the composite kidney end point compared to the clinical model.